Sign In
Buy CARA
$5.32
+0 (+0%)
At Close: Jul 14, 2025
Cara Therapeutics: 200% Upside Possible With FDA Approval
08:20am, Wednesday, 11'th Aug 2021
Cara Therapeutics: 200% Upside Possible With FDA Approval
Cara Therapeutics, Inc. (CARA) CEO Derek Chalmers on Q2 2021 Results - Earnings Call Transcript
10:37pm, Monday, 09'th Aug 2021
Cara Therapeutics, Inc. (CARA) CEO Derek Chalmers on Q2 2021 Results - Earnings Call Transcript
Cara Therapeutics (CARA) Reports Q2 Loss, Misses Revenue Estimates
06:28pm, Monday, 09'th Aug 2021
Cara (CARA) delivered earnings and revenue surprises of -10.91% and -100.00%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Cara Therapeutics: Q2 Earnings Insights
04:56pm, Monday, 09'th Aug 2021
Shares of Cara Therapeutics (NASDAQ:CARA) decreased in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 12.96% year over year to ($0.61), whic
Cara Therapeutics (CARA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
04:46pm, Monday, 02'nd Aug 2021
Cara (CARA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cara Therapeutics to Announce Second Quarter 2021 Financial Results on August 9, 2021
04:01pm, Monday, 02'nd Aug 2021
STAMFORD, Conn., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alle
Cara Therapeutics: PDUFA Ahead Makes Current Drop Attractive
08:00am, Monday, 19'th Jul 2021
Cara Therapeutics: PDUFA Ahead Makes Current Drop Attractive
How to Buy Biotech Stocks This Summer
06:10am, Saturday, 12'th Jun 2021
It pays to know what could cause them to move and when.
Is Cara Therapeutics a Buy for Summer 2021?
06:41am, Saturday, 29'th May 2021
The future of this troubled clinical-stage biotech rests on a single drug candidate that management hopes will treat an extremely common condition.
12 Cannabis Stocks That Lit Up Wall Street This Week
10:11am, Friday, 28'th May 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continue
Is Cara Therapeutics a Buy?
06:30am, Sunday, 23'rd May 2021
Maybe, if you're itching to speculate.
Here Are the Cannabis Stocks That Caught Fire This Week
08:19am, Friday, 14'th May 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continue
Cara Therapeutics, Inc. (CARA) CEO Derek Chalmers on Q1 2021 Results - Earnings Call Transcript
11:37pm, Monday, 10'th May 2021
Cara Therapeutics, Inc. (CARA) CEO Derek Chalmers on Q1 2021 Results - Earnings Call Transcript
Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates
06:47pm, Monday, 10'th May 2021
Cara (CARA) delivered earnings and revenue surprises of 24.19% and -80.94%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Cara Therapeutics: Q1 Earnings Insights
04:49pm, Monday, 10'th May 2021
Shares of Cara Therapeutics (NASDAQ:CARA) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 24.19% year over year to ($0.47), which bea
